Avid Bioservices Inc (CDMO)

[itsabouttime]

Front page Wash Post article on immunotherapy combo treatments
By Lenny Bernstein and Brady Dennis May 28 at 4:37 PM

old news but interesting

...........................
One advance may involve using checkpoint inhibitors in combination with each other, with other drugs that target specific tumors or with chemotherapy. In a study of 142 patients published May 21 in the New England Journal of Medicine, researchers showed a startling 61 percent response rate when they treated one kind of melanoma with both ipilimumab and nivolumab, although the side effects were worse than they were for people who took ipilimumab alone.

“I do think that it is a very amazing time in our field,” said Jedd D. Wolchok, associate director of the Ludwig Center for Cancer Immuno­therapy at Memorial Sloan Kettering and one of the researchers in that study. “It’s taken a long time for us to get here. There were many decades of challenge to prove that modulation of the immune system is a standard and impactful way to treat cancer.

“But now we have shown that. And now the remaining job is to extend the benefits to more patients and more types of cancer.”




Here is link

http://www.washingtonpost.com/national/health-science/unleashing-the-immune-system-in-the-fight-against-cancer/2015/05/28/c0fb2694-00bf-11e5-805c-c3f407e5a9e9_story.html